Oblita Therapeutics

Developer of therapeutics for infectious diseases

placeZoersel, Flanders, Belgium calendar_todayFounded 2016 language oblita.be

Registered entities

Innovation

7 patent families (5 granted) — focus: Human necessities, Emerging technologies; filing pace steady. Cited 58 times.

YearFilings
20161
20173
20181
20192
20201
20211
20221
20231
20241
20251
20261

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon